Overall, these findings suggest that the low expression of CHST4 in HBV-HCC may upregulate HBV expression and regulate spliceosome and ribonucleoprotein complex biogenesis to promote malignant behaviors. Here, CHST4 is linked to hepatocellular carcinoma.